Body surface area [Regulatives / Guidelines]

posted by Rock – India, 2018-02-12 10:47 (2286 d 20:50 ago) – Posting: # 18407
Views: 1,382

Dear Members
Please let me know, if body surface area (BSA) needs to be used for dose calculation in case of non-NTI drugs and in healthy subjects.

Also, confirm if an infusion study with long washout period which anticipated to significant change in weight, results in different dosages across the periods will require dose normalization?

Complete thread:

UA Flag
Activity
 Admin contact
23,029 posts in 4,834 threads, 1,641 registered users;
37 visitors (0 registered, 37 guests [including 9 identified bots]).
Forum time: 08:37 CEST (Europe/Vienna)

The most erroneous stories are those we think we know best–
and therefore never scrutinize or question.    Stephen Jay Gould

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5